Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astigmatism axis before and after cycloplegic refraction
IRCT20171227038103N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cyclopentolate and phenylephrine in astigmatism, sponsored by Zahedan University of Medical Sciences. Primary endpoint: Astigmatism axis angle. Started Jan 2018; status: completed.
02
Drugs
cyclopentolatephenylephrine
03
Conditions
astigmatism
Beyond the preview
Go deeper on IRCT20171227038103N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171227038103N1.